106 related articles for article (PubMed ID: 10718483)
1. Quantitation of erbB-2 gene copy number in breast cancer by an improved polymerase chain reaction (PCR) technique, competitively differential PCR.
Deng G; Kim YS
Breast Cancer Res Treat; 1999 Dec; 58(3):213-7. PubMed ID: 10718483
[TBL] [Abstract][Full Text] [Related]
2. Amplifications of oncogene erbB-2 and chromosome 20q in breast cancer determined by differentially competitive polymerase chain reaction.
Deng G; Yu M; Chen LC; Moore D; Kurisu W; Kallioniemi A; Waldman FM; Collins C; Smith HS
Breast Cancer Res Treat; 1996; 40(3):271-81. PubMed ID: 8883970
[TBL] [Abstract][Full Text] [Related]
3. Measuring c-erbB-2 oncogene amplification in fresh and paraffin-embedded tumors by competitive polymerase chain reaction.
Sestini R; Orlando C; Zentilin L; Gelmini S; Pinzani P; Bianchi S; Selli C; Giacca M; Pazzagli M
Clin Chem; 1994 Apr; 40(4):630-6. PubMed ID: 7511998
[TBL] [Abstract][Full Text] [Related]
4. Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.
Brandt B; Vogt U; Harms F; Bosse U; Zänker KS; Assmann G
Gene; 1995 Jun; 159(1):29-34. PubMed ID: 7607569
[TBL] [Abstract][Full Text] [Related]
5. Detection of HER-2/neu gene amplification in breast cancer using a novel polymerase chain reaction/ligase detection reaction technique.
Nathanson DR; Nash GM; Chen B; Gerald W; Paty PB
J Am Coll Surg; 2003 Sep; 197(3):419-25. PubMed ID: 12946797
[TBL] [Abstract][Full Text] [Related]
6. Detection of c-erbB-2 gene amplification in nipple discharge by means of polymerase chain reaction.
Motomura K; Koyama H; Noguchi S; Inaji H; Azuma C
Breast Cancer Res Treat; 1995; 33(1):89-92. PubMed ID: 7749137
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
Brandt B; Vogt U; Schlotter CM; Jackisch C; Werkmeister R; Thomas M; von Eiff M; Bosse U; Assmann G; Zänker KS
Gene; 1995 Jun; 159(1):35-42. PubMed ID: 7607571
[TBL] [Abstract][Full Text] [Related]
8. An improved method for semiquantification of gene amplification from archival material.
Underwood MA; Bartlett JM; Cooke TG
PCR Methods Appl; 1994 Dec; 4(3):178-84. PubMed ID: 7580903
[TBL] [Abstract][Full Text] [Related]
9. Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies.
de Cremoux P; Martin EC; Vincent-Salomon A; Dieras V; Barbaroux C; Liva S; Pouillart P; Sastre-Garau X; Magdelenat H
Int J Cancer; 1999 Oct; 83(2):157-61. PubMed ID: 10471520
[TBL] [Abstract][Full Text] [Related]
10. Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer.
Farshid G; Cheetham G; Davies R; Moore S; Rudzki Z
Diagn Mol Pathol; 2011 Mar; 20(1):11-7. PubMed ID: 21326034
[TBL] [Abstract][Full Text] [Related]
11. ERBB2 gene amplification detected by fluorescent differential polymerase chain reaction in paraffin-embedded breast carcinoma tissues.
An HX; Niederacher D; Beckmann MW; Göhring UJ; Scharl A; Picard F; van Roeyen C; Schnürch HG; Bender HG
Int J Cancer; 1995 Oct; 64(5):291-7. PubMed ID: 7591299
[TBL] [Abstract][Full Text] [Related]
12. Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.
Järvinen TA; Tanner M; Rantanen V; Bärlund M; Borg A; Grénman S; Isola J
Am J Pathol; 2000 Mar; 156(3):839-47. PubMed ID: 10702400
[TBL] [Abstract][Full Text] [Related]
13. Determination of amplification level of the c-erbB-2 proto-oncogene in human breast carcinomas: a comparative study between non-radioactive and radioactive labelling.
Edorh A; Parache RM; N'Sossani B; Bottin MC; Merlin JL; Colosetti P; Guillemin F; Le Faou A; Rihn B
Cell Mol Biol (Noisy-le-grand); 1995 Nov; 41(7):967-73. PubMed ID: 8595375
[TBL] [Abstract][Full Text] [Related]
14. Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients.
Suo Z; Daehli KU; Lindboe CF; Borgen E; Bassarova A; Nesland JM
Int J Surg Pathol; 2004 Oct; 12(4):311-8. PubMed ID: 15494857
[TBL] [Abstract][Full Text] [Related]
15. Comparison of differential PCR and immunohistochemistry for the evaluation of c-erbB-2 in breast carcinoma and relationship to other prognostic factors.
Erdogan S; Ergin M; Tuncer I
Neoplasma; 2003; 50(5):326-30. PubMed ID: 14628084
[TBL] [Abstract][Full Text] [Related]
16. [Her-2 gene dosage analysis in human breast cancer by PCR with internal standard].
Matsenko NIu; Kovalenko SP
Mol Gen Mikrobiol Virusol; 2006; (1):34-8. PubMed ID: 16512610
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of c-erbB-2 gene amplification in breast cancer tissue by competitive PCR.
Okuyama N; Hatano Y; Park Y; Shimatani S; Sasamoto S; Katou N; Takagi K; Yamazaki S; Inoue A; Hemmi H; Shimatake H; Yanagida M; Miura M
Tumour Biol; 1999; 20(3):153-61. PubMed ID: 10213923
[TBL] [Abstract][Full Text] [Related]
18. Frequent co-amplification of two different regions on 17q in aneuploid breast carcinomas.
Latham C; Zhang A; Nalbanti A; Månér S; Zickert P; Blegen H; Zetterberg A
Cancer Genet Cytogenet; 2001 May; 127(1):16-23. PubMed ID: 11408059
[TBL] [Abstract][Full Text] [Related]
19. The c-erbB-2 oncogene amplification by competitive PCR in aneuploid cell clones flow sorted from breast cancer samples.
Vona G; Caldini A; Sestini R; Rapi S; Bianchi S; Fanelli A; Pazzagli M; Orlando C
Clin Chem Lab Med; 1999 Jun; 37(6):649-54. PubMed ID: 10475073
[TBL] [Abstract][Full Text] [Related]
20. [Amplification of oncogenes HER2, mdm-2 and myc in breast cancer determined by modified competitive PCR].
Deng GR; He LW; Lu YY
Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):100-3, 127. PubMed ID: 7767763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
